Insider Transactions in Q1 2022 at Boston Scientific Corp (BSX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 01
2022
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
1,832
-1.14%
|
$76,944
$42.48 P/Share
|
|
Jan 01
2022
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
5,614
+3.39%
|
-
|
|
Jan 01
2022
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,179
-5.11%
|
$49,518
$42.48 P/Share
|
|
Jan 01
2022
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
3,367
+12.74%
|
-
|
|
Jan 01
2022
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
7,099
-3.26%
|
$298,158
$42.48 P/Share
|
|
Jan 01
2022
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
14,035
+6.06%
|
-
|
|
Jan 01
2022
|
Edward F Mackey EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
3,068
-9.15%
|
$128,856
$42.48 P/Share
|
|
Jan 01
2022
|
Edward F Mackey EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
9,824
+22.65%
|
-
|
|
Jan 01
2022
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,545
-1.12%
|
$988,890
$42.48 P/Share
|
|
Jan 01
2022
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
60,635
+2.8%
|
-
|
|
Jan 01
2022
|
Ian T Meredith EVP Global Chief Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,265
-4.23%
|
$53,130
$42.48 P/Share
|
|
Jan 01
2022
|
Ian T Meredith EVP Global Chief Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,649
+10.88%
|
-
|
|
Jan 01
2022
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
3,265
-2.28%
|
$137,130
$42.48 P/Share
|
|
Jan 01
2022
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
10,105
+6.59%
|
-
|
|
Jan 01
2022
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
SELL
Payment of exercise price or tax liability
|
Direct |
2,346
-1.35%
|
$98,532
$42.48 P/Share
|
|
Jan 01
2022
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
BUY
Exercise of conversion of derivative security
|
Direct |
6,175
+3.43%
|
-
|
|
Jan 01
2022
|
David A Pierce EVP Pres MedSurg |
SELL
Payment of exercise price or tax liability
|
Direct |
2,821
-31.41%
|
$118,482
$42.48 P/Share
|
|
Jan 01
2022
|
David A Pierce EVP Pres MedSurg |
BUY
Exercise of conversion of derivative security
|
Direct |
8,982
+50.0%
|
-
|
|
Jan 01
2022
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,382
-2.82%
|
$58,044
$42.48 P/Share
|
|
Jan 01
2022
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
3,929
+7.41%
|
-
|
|
Jan 01
2022
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
3,472
-3.76%
|
$145,824
$42.48 P/Share
|
|
Jan 01
2022
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
6,175
+6.27%
|
-
|